SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.

Unicycive Therapeutics Inc

Unicycive Therapeutics is trending after receiving a Complete Response Letter (CRL) from the FDA for its lead drug candidate, OLC, which cited manufacturing deficiencies at a third-party vendor, not issues with the drug's efficacy or safety. The community is weighing the short-term delay and potential for future dilution against OLC's strong clinical profile and the company's plan to resubmit for possible approval in the first half of the coming year. Many investors see this as a long-term opportunity, emphasizing that the drug's core benefits for dialysis patients remain intact despite regulatory setbacks.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences (GLSI) is trending due to promising preliminary open-label Phase 3 trial results for its breast cancer immunotherapy, showing an 80% reduction in recurrence rates for a specific patient arm. This positive development, combined with high short interest, a soaring cost-to-borrow, and low share availability, is fueling community speculation about a significant short squeeze and potential buyout offers. Investors are also noting strong insider confidence and the company's strategic financial position, de-risking future prospects.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust is experiencing significant momentum, largely fueled by escalating global scarcity concerns and China's impending silver export restrictions, alongside robust industrial demand for critical technologies. Community sentiment is sharply divided between those anticipating a 'generational' price squeeze towards triple digits and warnings of an 'overbought' bubble poised for a sharp correction, reminiscent of past speculative surges in precious metals.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp (UAMY) is trending amid escalating geopolitical concerns over critical minerals, particularly antimony, with recent reports highlighting China's tightened export controls. The company is actively discussed as the sole domestic supplier of military-grade antimony to the U.S. government, securing substantial defense contracts, yet the community is debating persistent market manipulation and short activity that appears to be suppressing its price. Despite recent volatility, many investors express strong long-term conviction, pointing to its strategic importance and ambitious growth targets into 2026, while anticipating imminent positive news or government support.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending following positive news, including significant CEPI funding for its pandemic influenza vaccine candidate and a favorable EMA opinion on its next-generation COVID-19 vaccine. This has ignited bullish community sentiment, with many anticipating a short squeeze and long-term pipeline success despite ongoing skepticism and legal challenges. Investors are debating if the stock, often seen as a biotech sector laggard, is poised for a rebound fueled by institutional interest and its oncology partnership with Merck.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is generating significant discussion driven by its strategic partnership to integrate at-home exam technology and speculation surrounding substantial government initiatives in rural healthcare. While many express acute frustration regarding current leadership and past capital allocation, a strong bullish contingent believes the company is deeply undervalued and poised for a major rebound as a global leader in the rapidly expanding AI healthcare sector.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy (EOSE) is trending amid discussions around its recent strategic financing and the U.S. Department of Energy taking a warrant, which bulls view as a significant derisking event to scale manufacturing for AI data centers and grid demands. While community sentiment is mixed on execution risk and dilution concerns, many anticipate substantial growth in the long-duration energy storage market. The company's unique non-lithium battery technology positions it to capitalize on increasing demand and government incentives, with focus on its path to consistent profitability.

Li Auto, Inc. engages in the design, development, manufacture, and sale of premium smart electric vehicles. Its products include Li MEGA, a high-tech flagship family MPV, Li L9, a six-seat flagship family SUV, and Li L8, a six-seat premium family SUV, and Li L7, a five-seat flagship family SUV. The firm also offers in-house development efforts on its proprietary range extension system, next-generation electric vehicle technology, and smart vehicle solutions. The company was founded by Xiang Li in April 2015 and is headquartered in Beijing, China.

Li Auto Inc - ADR

Li Auto is actively discussed amid recent financial reports reflecting reduced delivery projections and intensifying competition within the demanding Chinese EV market. While the company is pushing new models and seeing unexpected success with its AI-powered smart glasses, community chatter highlights concerns over vehicle quality issues and aggressive rival offerings. Investors are weighing the company's long-term profitability and expansion strategies against immediate market headwinds.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is trending due to robust Q3 earnings, exceeding revenue guidance with significant year-over-year growth, and maintaining a strong balance sheet with zero debt. Community discussion highlights sustained adoption across industrial robotics, smart infrastructure, and defense, a strategic diversification further bolstered by competitor consolidation and positive analyst sentiment, despite recent market volatility.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is a central topic as investors keenly await the expected delivery of its 100-qubit chip and an upcoming partnership with NVIDIA, both viewed as pivotal catalysts. Bulls foresee a significant rally and short squeeze, while bears highlight past missed deadlines, insider selling, and the company's high valuation. This sharp divergence underscores the speculative, high-risk discussions surrounding the stock within the broader quantum computing sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


ceovindiesel

ceo vindiesel